Abstract
Microglia are a self-sustained population of immune/myeloid cells present throughout the central nervous system (CNS). Microglia are in a “resting” state in the normal adult CNS. They turn “active” in injury and disease (e.g., trauma, neurodegeneration, and infection). Activated microglia can be beneficial as well as detrimental/neurotoxic. The innate-immune function of phagocytosis of tissue debris, neurotoxic factor, and pathogens is a beneficial function of microglia. The current manuscript reviews the role of Galectin-3 (known also as MAC-2; Galectin-3/MAC-2) in the activation of the phagocytosis of degenerated myelin that is mediated by complement receptor-3 (known also as MAC-1; CD11b/CD18; αMβ2 integrin) and SRA (scavenger receptor-AI/II). Observations suggest that Galectin-3/MAC-2 may act as a molecular switch that activates phagocytosis by up-regulating and prolonging KRas-GTP-dependent PI3K (phosphatidylinositol 3-kinase) activity. A similar mechanism may regulate the phagocytosis of other tissue debris, neurotoxic factors and pathogens in neurodegenerative and infectious diseases.
Similar content being viewed by others
References
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. (2007). Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nature Neuroscience, 10, 1538–1543.
Alliot, F., Godin, I., & Pessac, B. (1999). Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Developmental Brain Research, 117, 145–152.
Ashery, U., Yizhar, O., Rotblat, B., Elad-Sfadia, G., Barkan, B., Haklai, R., et al. (2006). Spatiotemporal organization of Ras signaling: Rasosomes and the Galectin switch. Cellular and Molecular Neurobiology, 26, 471–495.
Be'eri, H., Reichert, F., Saada, A., & Rotshenker, S. (1998). The cytokine network of Wallerian degeneration: IL-10 and GM-CSF. European Journal of Neuroscience, 10, 2707–2713.
Bell, M. D., Lopez-Gonzalez, R., Lawson, L., Hughes, D., Fraser, I., Gordon, S., et al. (1994). Upregulation of the macrophage scavenger receptor in response to different forms of injury in the CNS. Journal of Neurocytology, 23, 605–613.
Block, M. L., Zecca, L., & Hong, J. S. (2007). Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nature Reviews Neuroscience, 8, 57–69.
Cohen, G., Makranz, C., Spira, M., Kodama, T., Reichert, F., & Rotshenker, S. (2006). Non-PKC DAG/Phorbol-Ester receptor(s) inhibit complement receptor-3 and nPKC inhibit scavenger receptor-AI/II-mediated myelin phagocytosis but cPKC, PI3K, and PLCgamma activate myelin phagocytosis by both. Glia, 53, 538–550.
Dumic, J., Dabelic, S., & Flogel, M. (2006). Galectin-3: An open-ended story. Biochimica Biophysica Acta, 1760, 616–635.
Gao, H. M., & Hong, J. S. (2008). Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends in Immunology, 29, 357–365.
Griffin, J. W., George, R., Lobato, C., Tyor, W. R., Yan, L. C., & Glass, J. D. (1992). Macrophage responses and myelin clearance during Wallerian degeneration: Relevance to immune-mediated demyelination. Journal of Neuroimmunology, 40, 153–165.
Hanisch, U. K., & Kettenmann, H. (2007). Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nature Neuroscience, 10, 1387–1394.
Hannila, S. S., Siddiq, M. M., & Filbin, M. T. (2007). Therapeutic approaches to promoting axonal regeneration in the adult mammalian spinal cord. International Review of Neurobiology, 77, 57–105.
Ho, M. K., & Springer, T. A. (1982). Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. Journal of Immunology, 128, 1221–1228.
Kotter, M. R., Li, W. W., Zhao, C., & Franklin, R. J. M. (2006). Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. Journal of Neuroscience, 26, 328–332.
Kreutzberg, G. W. (1996). Microglia: A sensor for pathological events in the CNS. Trends in Neurosciences, 19, 312–318.
Makranz, C., Cohen, G., Baron, A., Levidor, L., Kodama, T., Reichert, F., et al. (2004). Phosphatidylinositol 3-kinase, phosphoinositide-specific phospholipase-Cgamma and protein kinase-C signal myelin phagocytosis mediated by complement receptor-3 alone and combined with scavenger receptor-AI/II in macrophages. Neurobiology of Disease, 15, 279–286.
McKerracher, L., & David, S. (2004). Easing the brakes on spinal cord repair. Natural Medicines, 10, 1052–1053.
Mead, R. J., Singhrao, S. K., Neal, J. W., Lassmann, H., & Morgan, B. P. (2002). The membrane attack complex of complement causes severe demyelination associated with acute axonal injury. Journal of Immunology, 168, 458–465.
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U. K., Mack, M., et al. (2007). Microglia in the adult brain arise from Ly6ChiCCR2+ monocytes only under defined host conditions. Nature Neuroscience, 10, 1544–1553.
Perry, V. H., Brown, M. C., & Gordon, S. (1987). The macrophage response to central and peripheral nerve injury. A possible role for macrophages in regeneration. Journal of Experimental Medicine, 165, 1218–1223.
Reichert, F., & Rotshenker, S. (1996). Deficient activation of microglia during optic nerve degeneration. Journal of Neuroimmunology, 70, 153–161.
Reichert, F., & Rotshenker, S. (1999). Galectin-3/MAC-2 in experimental allergic encephalomyelitis. Experimental Neurology, 160, 508–514.
Reichert, F., & Rotshenker, S. (2003). Complement-receptor-3 and scavenger-receptor-AI/II mediated myelin phagocytosis in microglia and macrophages. Neurobiology of Disease, 12, 65–72.
Reichert, F., Saada, A., & Rotshenker, S. (1994). Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: Phagocytosis and the galactose-specific lectin MAC-2. Journal of Neuroscience, 14, 3231–3245.
Reichert, F., Slobodov, U., Makranz, C., & Rotshenker, S. (2001). Modulation (inhibition and augmentation) of complement receptor-3-mediated myelin phagocytosis. Neurobiology of Disease, 8, 504–512.
Rinner, W. A., Bauer, J., Schmidts, M., Lassmann, H., & Hickey, W. F. (1995). Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: An investigation using rat radiation bone marrow chimeras. Glia, 14, 257–266.
Rio-Hortega, P. d. (1932). Microglia. In W. Penfield (Ed.), Cytology and cellular pathology of the nervous system (pp. 481–534). New York: Hafner.
Rotshenker, S. (2003). Microglia and macrophage activation and the regulation of complement-receptor-3 (CR3/MAC-1)-mediated myelin phagocytosis in injury and disease. Journal of Molecular Neuroscience, 21, 65–72.
Rotshenker, S., Reichert, F., Gitik, M., Haklai, R., Elad-Sfadia, G., & Kloog, Y. (2008). Galectin3/MAC-2, Ras and PI3K activate complement receptor-3 and scavenger receptor-AI/II mediated myelin phagocytosis in microglia. Glia, 56, 1607–1613.
Saada, A., Reichert, F., & Rotshenker, S. (1996). Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. Journal of Cell Biology, 133, 159–167.
Silverman, B. A., Carney, D. F., Johnston, C. A., Vanguri, P., & Shin, M. L. (1984). Isolation of membrane attack complex of complement from myelin membranes treated with serum complement. Journal of Neurochemistry, 42, 1024–1029.
Skaper, S. D. (2007). The brain as a target for inflammatory processes and neuroprotective strategies. Annals of the New York Academy of Sciences, 1122, 23–34.
Slobodov, U., Reichert, F., Mirski, R., & Rotshenker, S. (2001). Distinct inflammatory stimuli induce different patterns of myelin phagocytosis and degradation in recruited macrophages. Experimental Neurology, 167, 401–409.
Smith, M. E. (2001). Phagocytic properties of microglia in vitro: Implications for a role in multiple sclerosis and EAE. Microscopy Research and Technique, 54, 81–94.
Stoll, G., Jander, S., & Myers, R. R. (2002). Degeneration and regeneration of the peripheral nervous system: From Augustus Waller’s observations to neuroinflammation. Journal of the Peripheral Nervous System, 7, 13–27.
Yang, R. Y., Rabinovich, G. A., & Liu, F. T. (2008). Galectins: Structure, function and therapeutic potential. Expert Reviews in Molecular Medicine, 10, e17.
Yiu, G., & He, Z. (2006). Glial inhibition of CNS axon regeneration. Nature Reviews Neuroscience, 7, 617–627.
Acknowledgments
Studies related to the involvement of Galecrin-3/MAC-2 in the signaling of myelin phagocytosis were supported by the Israel Science Foundation (grant No. 11/06 to S. Rotshenker).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rotshenker, S. The Role of Galectin-3/MAC-2 in the Activation of the Innate-Immune Function of Phagocytosis in Microglia in Injury and Disease. J Mol Neurosci 39, 99–103 (2009). https://doi.org/10.1007/s12031-009-9186-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-009-9186-7